title: Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.
authors.affiliation: Leeds General Infirmary, Leeds, UK.
authors.forename: Sarah J
authors.initials: SJ
authors.lastname: Bingham
authors.forename: Maya H
authors.initials: MH
authors.lastname: Buch
authors.forename: Michael A
authors.initials: MA
authors.lastname: Kerr
authors.forename: Paul
authors.initials: P
authors.lastname: Emery
authors.forename: Anabela Tavares
authors.initials: AT
authors.lastname: Valadäo Barcelos
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000974:Antibodies, Antinuclear / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000276:immunology; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D004359:Drug Therapy, Combination; D006801:Humans; D000069285:Infliximab; D007555:Isoxazoles / Q000009:adverse effects* / Q000276:immunology; D000077339:Leflunomide
chemical_list: D000276:Adjuvants, Immunologic; D000974:Antibodies, Antinuclear; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007555:Isoxazoles; D000069285:Infliximab; D000077339:Leflunomide